From Long COVID to PMS: Alzchem is an innovation leader in creatine
Alzchem supports many scientific studies to generate new insights into the effects and applications of creatine, particularly in the health sector. In order to quickly identify new trends and efficiently network researchers, the company has set up a “Scientific Advisory Board” (SAB) consisting of world-renowned scientists and universities. The main objective of all participating researchers is to deepen existing knowledge of the effects of creatine, to generate new knowledge and to research new applications. Only Alzchem creatine products are used in the studies (Creapure®, Creavitalis®).
Alzchem is currently supporting over twenty studies involving research on creatine. The following are particularly noteworthy:
- New Zealand: Research on the use of creatine during pregnancy
- Brazil: Study on the effect of creatine on PMS symptoms, conducted with a Brazilian top women's soccer team
- Spain: Investigation into the effect of creatine on various parameters in older adults
- Germany: Research on creatine in relation to long or post COVID symptoms
The different applications of creatine in these areas can be traced back to its important role in the energy metabolism of body cells. Creatine is crucial for cellular energy metabolism. Whenever the body needs energy, creatine is needed.
Contact
Robert Alber
VP Human Nutrition, Alzchem Group
About Alzchem
Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem offers answers to various global developments such as climate change, population growth and increasing life expectancy. We deliver solutions through brands and products of the highest quality and through a sustainable vision to help shape global developments.
The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments.
The company employs around 1,690 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA of EUR 81.4 million in 2023.